Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe
- 958 Downloads
This study examined the prevalence and correlates of use of complementary and alternative medicine (CAM) among a sample of children with autism spectrum disorder (ASD) < 7 years in 18 European countries (N = 1,680). Forty-seven percent of parents reported having tried any CAM approach in the past 6 months. Diets and supplements were used by 25 % of the sample and mind–body practices by 24 %; other unconventional approaches were used by 25 % of the families, and a minority of parents reported having tried any invasive or potentially harmful approach (2 %). Parents in Eastern Europe reported significantly higher rates of CAM use. In the total sample, children with lower verbal ability and children using prescribed medications were more likely to be receiving diets or supplements. Concurrent use of high levels of conventional psychosocial intervention was significantly associated with use of mind–body practices. Higher parental educational level also increased the likelihood of both use of diets and supplements and use of mind–body practices.
What is Known:
• Use of complementary and alternative medicine (CAM) in children with autism spectrum disorder is common.
• In non-EU samples, parents with higher educational level and parents of low functioning children are more likely to use CAM with their children.
What is New:
• This study provides the first data on prevalence and correlates of use of CAM approaches in a large sample of young children with autism in Europe (N = 1,680).
• Rates of CAM use were particularly high in Eastern Europe and correlates of use varied by type of CAM across Europe.
KeywordsAutism spectrum disorder Complementary and alternative medicine Europe Diets Supplements Mind–body practices
Analysis of variance
Autism spectrum disorder
Complementary and alternative medicine
National Center for Complementary and Alternative Medicine
Randomised controlled trial
We are grateful to all the parents who participated in the study and to the parents associations that were involved in recruiting the participants. This research was supported by the COST Action BM1004 funded by the European Science Foundation. TC also received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115,300, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007 – 2013) and EFPIA companies’ in kind contribution. It was made possible by the clinicians and researchers who are members of the COST ESSEA (http://www.cost-essea.com/) and EU-AIMS (http://www.eu-aims.eu/) networks. The COST ESSEA work group 4 also includes: Anett Kaale (Norway), Bernadette Rogé and Frederique Bonnet-Brilhaut (France), Iris Oosterling (The Netherlands), Selda Ozdemir (Turkey), Antonio Narzisi and Filippo Muratori (Italy), Joaquin Fuentes (Spain), Mikael Heimann (Sweden), Michele Noterdaeme, Christine Freitag, Luise Poustka and Judith Sinzig (Germany) and Jonathan Green (UK).
Conflict of Interest
All authors report no biomedical financial interests or potential conflict of interest.
ES, TC, HMC and PW made substantial contributions to conception and design of the study and to theanalysis and interpretation of data. ES, TC, HCM, PW and all members of the Working Group 4, COST Action‘Enhancing the Scientific Study of Early Autism’ made substanstial contributions to the acquisition of data. ES drafted the article and all authors revised it critically and gave final approval of the submitted version.
- 1.Akins RS, Krakowiak P, Angkustsiri K, Hertz-Picciotto I, Hansen RL (2014) Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. J Dev Behav Pediatr 35(1):1–10. doi: 10.1097/DBP.0000000000000013 PubMedCentralCrossRefPubMedGoogle Scholar
- 3.APA (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, ArlingtonGoogle Scholar
- 9.Eurostat tSOotEU (2014) Tertiary educational attainment by sex, age group 30–34 (t2020_41). doi:http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&init=1&plugin=1&language=en&pcode=t2020_41
- 10.FDA (2014) U.S. Food and Drug Administration website: Beware of false or misleading claims for treating autism http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm394757.htm. Accessed 16/10/2014
- 16.Holm M, Baird J, Kim Y, Rajora K, D’Silva D, Podolinsky L, Mazefsky C, Minshew N (2014) Therapeutic horseback riding outcomes of parent-identified goals for children with autism spectrum disorder: an ABA’ multiple case design examining dosing and generalization to the home and community. J Autism Dev Disord 44(4):937–947. doi: 10.1007/s10803-013-1949-x PubMedCentralCrossRefPubMedGoogle Scholar
- 18.James S, Montgomery P, Williams K (2011) Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 11Google Scholar
- 28.Nahin R, Barnes P, Stussman B, Bloom B (2009) Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007, vol 18, National Health Statistics Reports. National Center for Health Statistics, HyattsvilleGoogle Scholar
- 29.NICE (2013) Autism. The management and support of children and young people on the autism spectrum [CG170]. National Institute for Health and Care Excellence, LondonGoogle Scholar
- 33.Salomone E, Beranová Š, Bonnet-Brilhault F, Briciet Lauritsen M, Budisteanu M, Buitelaar JK, Canal-Bedia R, Felhosi G, Fletcher-Watson S, Fuentes J, Gallagher L, Garcia Primo P, Gliga F, Gomot M, Green J, Heimann M, Loa Jónsdóttir S, Kaale A, Kawa R, Kylliainen A, Lemcke S, Markovska-Simoska S, Marschik P, McConachie H, Moilanen I, Muratori F, Narzisi A, Noterdaeme M, Oliveira G, Oosterling I, Pijl M, Pop-Jordanova N, Poustka F, Roeyers H, Rogé B, Sinzig J, Vicente A, Warreyn P, Charman T (2015) Use of early intervention for young children with autism spectrum disorder across Europe. Autism: Int J Res Pract, in pressGoogle Scholar
- 35.Sinha Y, Silove N, Hayen A, Williams K (2011) Auditory integration training and other sound therapies for autism spectrum disorders (ASD). Cochrane Database Syst Rev 12Google Scholar
- 37.UN (2006) International Standard ISO 3166–1, Codes for the representation of names of countries and their subdivisions—part 1: Country codes, ISO 3166–1: 2006 (E/F). GenevaGoogle Scholar
- 38.Valicenti-McDermott M, Burrows B, Bernstein L, Hottinger K, Lawson K, Seijo R, Schechtman M, Shulman L, Shinnar S (2014) Use of complementary and alternative medicine in children with autism and other developmental disabilities: associations with ethnicity, child comorbid symptoms, and parental stress. J Child Neurol 29(3):360–367. doi: 10.1177/0883073812474489 CrossRefPubMedGoogle Scholar
- 40.Winburn E, Charlton J, McConachie H, McColl E, Parr J, O’Hare A, Baird G, Gringras P, Wilson D, Adamson A, Adams S, Le Couteur A (2014) Parents’ and child health professionals’ attitudes towards dietary interventions for children with autism spectrum disorders. J Autism Dev Disord 44(4):747–757. doi: 10.1007/s10803-013-1922-8 CrossRefPubMedGoogle Scholar
- 41.Zuzak TJ, Boňková J, Careddu D, Garami M, Hadjipanayis A, Jazbec J, Merrick J, Miller J, Ozturk C, Persson IAL, Petrova G, Saz Peiró P, Schraub S, Simões-Wüst AP, Steinsbekk A, Stockert K, Stoimenova A, Styczynski J, Tzenova-Savova A, Ventegodt S, Vlieger AM, Längler A (2013) Use of complementary and alternative medicine by children in Europe: published data and expert perspectives. Complement Ther Med 21(Supplement 1 (0)):S34–S47. doi: 10.1016/j.ctim.2012.01.001 CrossRefPubMedGoogle Scholar